BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31820090)

  • 1. Mineralocorticoid receptor antagonists lead to increased adenosine bioavailability and modulate contractile cardiac parameters.
    Hermidorff MM; de Assis LVM; Rodrigues JA; Soares LL; Andrade MHG; Natali AJ; Isoldi MC
    Heart Vessels; 2020 May; 35(5):719-730. PubMed ID: 31820090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-genomic effects of spironolactone and eplerenone in cardiomyocytes of neonatal Wistar rats: do they evoke cardioprotective pathways?
    Hermidorff MM; Faria Gde O; Amâncio Gde C; de Assis LV; Isoldi MC
    Biochem Cell Biol; 2015 Feb; 93(1):83-93. PubMed ID: 25488178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of CD73, equilibrative nucleoside transporters and inosine in rhythm and conduction disturbances mediated by adenosine A1 and A2A receptors in the developing heart.
    Robin E; Sabourin J; Marcillac F; Raddatz E
    J Mol Cell Cardiol; 2013 Oct; 63():14-25. PubMed ID: 23837961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoid receptor antagonists attenuate exaggerated exercise pressor reflex responses in hypertensive rats.
    Downey RM; Mizuno M; Mitchell JH; Vongpatanasin W; Smith SA
    Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H788-H794. PubMed ID: 28733447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hypoxic episode during cardiogenesis downregulates the adenosinergic system and alters the myocardial anoxic tolerance.
    Robin E; Marcillac F; Raddatz E
    Am J Physiol Regul Integr Comp Physiol; 2015 Apr; 308(7):R614-26. PubMed ID: 25632022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms for aldosterone and spironolactone-induced positive inotropic actions in the rat heart.
    Barbato JC; Rashid S; Mulrow PJ; Shapiro JI; Franco-Saenz R
    Hypertension; 2004 Nov; 44(5):751-7. PubMed ID: 15466666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential actions of eplerenone and spironolactone on the protective effect of testosterone against cardiomyocyte apoptosis in vitro.
    Sánchez-Más J; Turpín MC; Lax A; Ruipérez JA; Valdés Chávarri M; Pascual-Figal DA
    Rev Esp Cardiol; 2010 Jul; 63(7):779-87. PubMed ID: 20609311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A(1) and A(3) adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes.
    Gessi S; Merighi S; Stefanelli A; Fazzi D; Varani K; Borea PA
    Pharmacol Res; 2013 Oct; 76():157-70. PubMed ID: 23969284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineralocorticoid and angiotensin receptor antagonism during hyperaldosteronemia.
    Mihailidou AS; Mardini M; Funder JW; Raison M
    Hypertension; 2002 Aug; 40(2):124-9. PubMed ID: 12154101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.
    Nakagawa H; Oberwinkler H; Nikolaev VO; Gaßner B; Umbenhauer S; Wagner H; Saito Y; Baba HA; Frantz S; Kuhn M
    Circ Heart Fail; 2014 Sep; 7(5):814-21. PubMed ID: 25027872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective effects of adenosine A1 and A3 receptor activation during hypoxia in isolated rat cardiac myocytes.
    Safran N; Shneyvays V; Balas N; Jacobson KA; Nawrath H; Shainberg A
    Mol Cell Biochem; 2001 Jan; 217(1-2):143-52. PubMed ID: 11269659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postnatal development and LPS responsiveness of pulmonary adenosine receptor expression and of adenosine-metabolizing enzymes in mice.
    Metsola J; Maksimow M; Ojaniemi M; Metsola H; Marttila-Ichihara F; Vuolteenaho R; Yegutkin GG; Salmi M; Hallman M; Jalkanen S
    Pediatr Res; 2014 Dec; 76(6):515-21. PubMed ID: 25188742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction.
    Lax A; Sanchez-Mas J; Asensio-Lopez MC; Fernandez-Del Palacio MJ; Caballero L; Garrido IP; Pastor-Perez FJ; Januzzi JL; Pascual-Figal DA
    JACC Heart Fail; 2015 Jan; 3(1):50-58. PubMed ID: 25458175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the adenosine-A3 receptor stimulates matrix metalloproteinase-9 secretion by macrophages.
    Velot E; Haas B; Léonard F; Ernens I; Rolland-Turner M; Schwartz C; Longrois D; Devaux Y; Wagner DR
    Cardiovasc Res; 2008 Nov; 80(2):246-54. PubMed ID: 18653544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity.
    Hullin R; Métrich M; Sarre A; Basquin D; Maillard M; Regamey J; Martin D
    Cardiovasc Res; 2018 Feb; 114(2):272-281. PubMed ID: 29016737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineralocorticoid Receptor Blockade Improves Insulin Sensitivity in the Rat Heart and a Possible Molecular Mechanism.
    Wang M; Li Y; Zhou K; Zhang G; Wang Y; Liu T; Zhang Y; Guo A; An Y
    Cell Physiol Biochem; 2016; 39(3):860-70. PubMed ID: 27497962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficits in endogenous adenosine formation by ecto-5'-nucleotidase/CD73 impair neuromuscular transmission and immune competence in experimental autoimmune myasthenia gravis.
    Oliveira L; Correia A; Cristina Costa A; Guerra-Gomes S; Ferreirinha F; Magalhães-Cardoso MT; Vilanova M; Correia-de-Sá P
    Mediators Inflamm; 2015; 2015():460610. PubMed ID: 25691808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer.
    Kazemi MH; Raoofi Mohseni S; Hojjat-Farsangi M; Anvari E; Ghalamfarsa G; Mohammadi H; Jadidi-Niaragh F
    J Cell Physiol; 2018 Mar; 233(3):2032-2057. PubMed ID: 28233320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of the selective aldosterone receptor antagonist eplerenone to ACE inhibition in heart failure: effect on endothelial dysfunction.
    Schäfer A; Fraccarollo D; Hildemann SK; Tas P; Ertl G; Bauersachs J
    Cardiovasc Res; 2003 Jun; 58(3):655-62. PubMed ID: 12798439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of mineralocorticoid receptor antagonism by eplerenone.
    Hu X; Li S; McMahon EG; Lala DS; Rudolph AE
    Mini Rev Med Chem; 2005 Aug; 5(8):709-18. PubMed ID: 16101407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.